Health Enterprise Management Newsletter July 2012
Our quarterly journal club met on June 4 at the Allen Center to discuss the subject of technology assessment in the U.S. and explore lessons from international healthcare systems. The paper that was the basis of the discussion was:
Health Technology Assessment in Evidence-Based Health Care Reimbursement Decisions Around the World–An Overview
Paper Citation: O’Donnell JC, Pham SV, Pashos CL, et al. Health technology assessment in evidence-based health care reimbursement decisions around the world: an overview. Value Health 2009;12(Suppl. 2):S1-5.
The discussion leader was Giuseppe Turchetti, Ph.D., Professor at the Institute of Management at the Scuola Superiore Sant’Ana in Pisa, Italy. Professor Turchetti’ s academic interests are in technology assessment and insurance, in which areas he has published extensively. He is at Kellogg as a Fulbright Scholar until the end of August.
What Americans lack, that other countries have, are: a centralized mechanism for evaluating clinical effectiveness and price considerations in the technology approval decisions. Taking these concerns together means we do not have the mechanism (or desire) to make cost- effective technology implementation decisions.
Professor Turchetti’s presentation focused on how these issues are handled in Italy and the EU. His presentation is available for download (PPT 2 MB).
We thank Humana for again sponsoring the reception.
In anticipation of the next journal club in the fall quarter, please send any topic or article suggestions to Julie Gertz.
Back to the newsletter